Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label dose-titration trial of tolvaptan in SIADH-related hyponatremia
jRCT2080223457Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of tolvaptan in syndrome of inappropriate antidiuresis (SIAD) and hyponatraemia, sponsored by Otsuka Pharmaceutical Co., Ltd. Started Feb 2017; status: completed.
02
Drugs
tolvaptan
03
Conditions
syndrome of inappropriate antidiuresis (SIAD)hyponatraemia
Beyond the preview
Go deeper on jRCT2080223457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223457.